Leishmaniasis East Africa Platform (LEAP)
Founded: 2003, Khartoum, Sudan
60 members from over 20 institutions
The LEAP platform aims to strengthen clinical research capacity, which is lacking in part due to the remoteness and geographic spread of the patients, most of whom live in the most impoverished regions of Africa. The platform also is a base for ongoing educational cooperation between the countries in the East African region and standardization of procedures and practices within the region, as far as is possible within the confines of local
regulations. LEAP evaluates, validates, and registers new treatments that address regional needs for visceral leishmaniasis.
2nd LEAP Scientific Conference
The 2nd LEAP Scientific Conference ‘Scientific innovation and access for leishmaniasis management‘ will take place virtually on 2-4 November 2021.
DNDi and the LEAP platform invite individuals and institutions from the African continent and other parts of the world to submit abstracts by 27 August 2021 at 11:30pm EAT.
‘The Good Clinical Practice training presented me with a chance to not only expand my knowledge and skills but also handle study participants appropriately. It is a positive step towards becoming a globally certified clinical trial expert.’
Dr Eleni Ayele, Leishmaniasis Research and Treatment Centre at the Gondar University Hospital in Ethiopia